WO2010039917A3 - Compositions for use in identification of staphylococcus aureus - Google Patents

Compositions for use in identification of staphylococcus aureus Download PDF

Info

Publication number
WO2010039917A3
WO2010039917A3 PCT/US2009/059169 US2009059169W WO2010039917A3 WO 2010039917 A3 WO2010039917 A3 WO 2010039917A3 US 2009059169 W US2009059169 W US 2009059169W WO 2010039917 A3 WO2010039917 A3 WO 2010039917A3
Authority
WO
WIPO (PCT)
Prior art keywords
staphylococcus aureus
compositions
identification
mrsa
methicillin
Prior art date
Application number
PCT/US2009/059169
Other languages
French (fr)
Other versions
WO2010039917A2 (en
Inventor
Rangarajan Sampath
David J. Ecker
Thomas A. Hall
Lawrence B. Blyn
Rachael Kreft
Original Assignee
Ibis Biosciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ibis Biosciences, Inc. filed Critical Ibis Biosciences, Inc.
Publication of WO2010039917A2 publication Critical patent/WO2010039917A2/en
Publication of WO2010039917A3 publication Critical patent/WO2010039917A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Abstract

The present invention relates generally to the detection and identification of Staphylococcus aureus, such as methicillin-resistant Staphylococcus aureus (MRSA), and provides methods, compositions and kits useful for this purpose when combined, for example, with molecular mass or base composition analysis.
PCT/US2009/059169 2008-10-03 2009-10-01 Compositions for use in identification of staphylococcus aureus WO2010039917A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10274108P 2008-10-03 2008-10-03
US61/102,741 2008-10-03
US11897308P 2008-12-01 2008-12-01
US61/118,973 2008-12-01

Publications (2)

Publication Number Publication Date
WO2010039917A2 WO2010039917A2 (en) 2010-04-08
WO2010039917A3 true WO2010039917A3 (en) 2010-07-22

Family

ID=41396333

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/059169 WO2010039917A2 (en) 2008-10-03 2009-10-01 Compositions for use in identification of staphylococcus aureus

Country Status (1)

Country Link
WO (1) WO2010039917A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895311B1 (en) 2001-03-28 2014-11-25 Handylab, Inc. Methods and systems for control of general purpose microfluidic devices
US7956175B2 (en) 2003-09-11 2011-06-07 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
CA2869717C (en) 2012-04-13 2022-09-06 Becton, Dickinson And Company Reflex testing of samples using residual materials from a prior test
CN113215321B (en) * 2021-05-26 2022-09-30 北京毅新博创生物科技有限公司 Detection product for detecting genital tract pathogen by MALDI-TOF MS and application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1541696A1 (en) * 2003-12-09 2005-06-15 Institut Pasteur A DNA macro-array for staphylococcus aureus identification and typing
WO2006116127A2 (en) * 2005-04-21 2006-11-02 Isis Pharmaceuticals, Inc. Compositions for use in identification of bacteria
WO2008118809A1 (en) * 2007-03-23 2008-10-02 Ibis Biosciences, Inc. Compositions for use in identification of mixed populations of bioagents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1541696A1 (en) * 2003-12-09 2005-06-15 Institut Pasteur A DNA macro-array for staphylococcus aureus identification and typing
WO2006116127A2 (en) * 2005-04-21 2006-11-02 Isis Pharmaceuticals, Inc. Compositions for use in identification of bacteria
WO2008118809A1 (en) * 2007-03-23 2008-10-02 Ibis Biosciences, Inc. Compositions for use in identification of mixed populations of bioagents

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GRAVET A ET AL: "Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 436, no. 2, 2 October 1998 (1998-10-02), pages 202 - 208, XP004258421, ISSN: 0014-5793 *
TRISTAN A ET AL: "Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus", JOURNAL OF HOSPITAL INFECTION, ACADEMIC PRESS, LONDON, GB, vol. 65, 1 June 2007 (2007-06-01), pages 105 - 109, XP025322266, ISSN: 0195-6701, [retrieved on 20070529] *

Also Published As

Publication number Publication date
WO2010039917A2 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
WO2008129428A3 (en) Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
WO2007118222A3 (en) Compositions for the use in identification of fungi
WO2006116127A3 (en) Compositions for use in identification of bacteria
WO2007086904A3 (en) Compositions for use in identification of adenoviruses
WO2010039819A3 (en) Compositions for use in identification of fungi
WO2011045544A3 (en) Method for characterizing at least one microorganism by means of mass spectrometry
WO2009156462A3 (en) Organic compounds
WO2009085221A3 (en) Detection of methicillin-resistant staphylococcus aureus
WO2010077898A3 (en) Trans-chloro-3,3,3-trifluoropropene for use in chiller applications
WO2009129267A3 (en) Small molecule inhibitors of the pleckstrin homology domain and methods for using same
WO2008024473A3 (en) Mapping of genomic interactions
BR112014015909A8 (en) composition
WO2006094238A3 (en) Compositions for use in identification of adventitious viruses
WO2012020214A3 (en) Anti-microbial metal organic framework
HK1149950A1 (en) Novel compositions and related methods, coatings, and articles
WO2011047087A3 (en) Protein detection via nanoreporters
WO2007087534A3 (en) Methods, mixtures, kits and compositions pertaining to analyte determination
WO2010062377A3 (en) Methods and compositions for the detection and treatment of preeclampsia
WO2008157697A3 (en) Copolymer assay
WO2008122053A3 (en) Compositions, kits and related methods for the detection and/or monitoring of pseudomonas aeruginosa
WO2008140581A3 (en) Systems and methods for preparing and analyzing samples
EA200800713A1 (en) AMORPHOUS SOLID DISPERSIONS
WO2008140612A3 (en) Detection of staphylococcus aureus and identification of methicillin-resistant staphylococcus aureus
WO2009042270A3 (en) Reca inhibitors and their uses as microbial inhibitors or potentiators of antibiotic activity
WO2009155103A3 (en) Compositions for use in identification of tick-borne pathogens

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09793224

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09793224

Country of ref document: EP

Kind code of ref document: A2